Work

A Phase I Clinical Trial of Spicamycin Derivative KRN5500 (NSC 650426) Using a Phase I Accelerated Titration “2B” Design

Year: 2003

Type: article

Study design: Clinical Trial

Source: Investigational New Drugs

DOI: 10.1023/a:1022972427532

Authors: S.M. Gadgeel, R.R. Boinpally, L.K. Heilbrun, A. Wozniak, V. Jain, B. Redman, M. Zalupski, R. Wiegand, R. Parchment, P.M. LoRusso

Institutions: Wayne State University, The Barbara Ann Karmanos Cancer Institute, U-M Rogel Cancer Center

Language: English

Topic: Cancer therapeutics and mechanisms

Subfield: Molecular Biology

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

Funders: National Institutes of Health, National Cancer Institute

Awards: G148520442, G1611812476, Early Clinical Trials of New Anti-Cancer Agents, CANCER CENTER SUPPORT GRANT

OpenAlex ID: W1561840010

FWCI: 0.429

Cites: 22

Cited by: 20

Related to: 10